Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peng-Cheng He

Showing results (81-90 of 95) with videos related to

Pageof 10
Sort By:
BMC Cardiovascular Disorders|April 22, 2021
The association of baseline N-terminal pro-B-type natriuretic peptide with short and long-term prognosis following percutaneous coronary intervention in non-ST segment elevation acute coronary syndrome with multivessel coronary artery disease: a retrospective cohort studyWen-Fei He, Lei Jiang, Yi-Yue Chen, et al.
JAMA Internal Medicine|December 29, 2018
Association of Parenteral Anticoagulation Therapy With Outcomes in Chinese Patients Undergoing Percutaneous Coronary Intervention for Non-ST-Segment Elevation Acute Coronary SyndromeJi-Yan Chen, Peng-Cheng He, Yuan-Hui Liu, et al.
Blood Cancer Journal|November 20, 2022
An effective and chemotherapy-free strategy of all-trans retinoic acid and arsenic trioxide for acute promyelocytic leukemia in all risk groups (APL15 trial)Huai-Yu Wang, Sha Gong, Guo-Hui Li, et al.
Circulation. Cardiovascular Interventions|June 5, 2015
Safe limits of contrast vary with hydration volume for prevention of contrast-induced nephropathy after coronary angiography among patients with a relatively low risk of contrast-induced nephropathyYong Liu, Ji-Yan Chen, Ning Tan, et al.
Blood Advances|February 24, 2026
Phase 2 study of relmacabtagene autoleucel (CD19 CAR-T) for relapsed/refractory mantle cell lymphoma in Chinese adultsYan Xie, Ke-Shu Zhou, Lan-Fang Li, et al.
Bone Marrow Transplantation|December 2, 2024
Outcomes of allogeneic hematopoietic stem cell transplantation versus intensive chemotherapy in patients with myeloid sarcoma: a nationwide representative multicenter studyJie Sun, Yi-Cheng Zhang, Jia Wei, et al.
Clinical Pharmacology and Therapeutics|July 21, 2021
Association of Parenteral Anticoagulation Therapy With Outcomes in Non-ST-Segment Elevation Acute Coronary Syndrome Patients Without Invasive Therapy: Findings from the Improving Care for Cardiovascular Disease in China (CCC) projectYuan-Hui Liu, Hua-Lin Fan, Li-Huan Zeng, et al.
Haematologica|February 1, 2024
The outcome of allogeneic hematopoietic stem cell transplantation among elderly patients with severe aplastic anemia and a predictive model from the Chinese Blood and Marrow Transplant Registry groupZheng-Li Xu, Lan-Ping Xu, Yi-Cheng Zhang, et al.
The Oncologist|October 13, 2025
Real-world effectiveness of mitoxantrone hydrochloride liposome containing regimens in acute myeloid leukemiaTie-Jun Gong, Wei-Ming Li, Li Liu, et al.
Science Translational Medicine|April 1, 2026
Site-specific methylation of SRSF2<sup>P95H</sup> by SETD2 inhibits MDSC-mediated proinflammatory niche formation in mouse models of myelodysplastic syndromeZi-Juan Li, Mu-Ying Zhao, Roujia Wang, et al.
Pageof 10

Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
BMC Cardiovascular Disorders|April 22, 2021
The association of baseline N-terminal pro-B-type natriuretic peptide with short and long-term prognosis following percutaneous coronary intervention in non-ST segment elevation acute coronary syndrome with multivessel coronary artery disease: a retrospective cohort studyWen-Fei He, Lei Jiang, Yi-Yue Chen, et al.
JAMA Internal Medicine|December 29, 2018
Association of Parenteral Anticoagulation Therapy With Outcomes in Chinese Patients Undergoing Percutaneous Coronary Intervention for Non-ST-Segment Elevation Acute Coronary SyndromeJi-Yan Chen, Peng-Cheng He, Yuan-Hui Liu, et al.
Blood Cancer Journal|November 20, 2022
An effective and chemotherapy-free strategy of all-trans retinoic acid and arsenic trioxide for acute promyelocytic leukemia in all risk groups (APL15 trial)Huai-Yu Wang, Sha Gong, Guo-Hui Li, et al.
Circulation. Cardiovascular Interventions|June 5, 2015
Safe limits of contrast vary with hydration volume for prevention of contrast-induced nephropathy after coronary angiography among patients with a relatively low risk of contrast-induced nephropathyYong Liu, Ji-Yan Chen, Ning Tan, et al.
Blood Advances|February 24, 2026
Phase 2 study of relmacabtagene autoleucel (CD19 CAR-T) for relapsed/refractory mantle cell lymphoma in Chinese adultsYan Xie, Ke-Shu Zhou, Lan-Fang Li, et al.
Bone Marrow Transplantation|December 2, 2024
Outcomes of allogeneic hematopoietic stem cell transplantation versus intensive chemotherapy in patients with myeloid sarcoma: a nationwide representative multicenter studyJie Sun, Yi-Cheng Zhang, Jia Wei, et al.
Clinical Pharmacology and Therapeutics|July 21, 2021
Association of Parenteral Anticoagulation Therapy With Outcomes in Non-ST-Segment Elevation Acute Coronary Syndrome Patients Without Invasive Therapy: Findings from the Improving Care for Cardiovascular Disease in China (CCC) projectYuan-Hui Liu, Hua-Lin Fan, Li-Huan Zeng, et al.
Haematologica|February 1, 2024
The outcome of allogeneic hematopoietic stem cell transplantation among elderly patients with severe aplastic anemia and a predictive model from the Chinese Blood and Marrow Transplant Registry groupZheng-Li Xu, Lan-Ping Xu, Yi-Cheng Zhang, et al.
The Oncologist|October 13, 2025
Real-world effectiveness of mitoxantrone hydrochloride liposome containing regimens in acute myeloid leukemiaTie-Jun Gong, Wei-Ming Li, Li Liu, et al.
Science Translational Medicine|April 1, 2026
Site-specific methylation of SRSF2<sup>P95H</sup> by SETD2 inhibits MDSC-mediated proinflammatory niche formation in mouse models of myelodysplastic syndromeZi-Juan Li, Mu-Ying Zhao, Roujia Wang, et al.
Pageof 10